DBBF

Beta Ethereum Diversified Balance Mutual Fund (DBBF)

Market Open
ASX ASX
- Market Cap
148% Div Yield
4 Volume

Summary

DBBF trading today lower, a decrease of 0.46% from yesterday's close, completing a monthly increase of 2.74%. Over the past 12 months, DBBF stock gained 0.61%.
DBBF pays dividends to its shareholders, with the most recent payment made on Apr 16, 2025. The next estimated payment will be in 2 months ago on Apr 16, 2025 for a total of A$0.1016.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on ASX (AUD).
Want to track DBBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Beta Ethereum Diversified Balance Mutual Fund Dividends

DBBF
DBBF In 1 weeks
Estimated
Final
A$0.1 Per Share
DBBF
DBBF 2 months ago
Paid
Final
A$0.1 Per Share
DBBF
DBBF 5 months ago
Paid
Final
A$0.17 Per Share
DBBF
DBBF 8 months ago
Paid
Final
A$0.1 Per Share
DBBF
DBBF 11 months ago
Paid
Interim
A$0.55 Per Share
DBBF
DBBF 2 Apr 2024
Paid
Final
A$0.1 Per Share

Beta Ethereum Diversified Balance Mutual Fund Earnings

DBBF have yet to publish their earning reports.
DBBF
DBBF In 1 weeks
Estimated
Final
A$0.1 Per Share
DBBF
DBBF 2 months ago
Paid
Final
A$0.1 Per Share
DBBF
DBBF 5 months ago
Paid
Final
A$0.17 Per Share
DBBF
DBBF 8 months ago
Paid
Final
A$0.1 Per Share
DBBF
DBBF 11 months ago
Paid
Interim
A$0.55 Per Share
DBBF
DBBF 2 Apr 2024
Paid
Final
A$0.1 Per Share
DBBF have yet to publish their earning reports.

Beta Ethereum Diversified Balance Mutual Fund (DBBF) FAQ

On which exchange is it traded?

Beta Ethereum Diversified Balance Mutual Fund is listed on ASX.

What is its stock symbol?

The ticker symbol is DBBF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Beta Ethereum Diversified Balance Mutual Fund ever had a stock split?

No, there has never been a stock split.

Beta Ethereum Diversified Balance Mutual Fund Profile

ASX Exchange
Japan Country

Overview

Sysmex Corporation, originally known as TOA Medical Electronics Co., Ltd. before rebranding in October 1998, is a pioneer in the field of diagnostic instruments, reagents, and software development, manufacturing, and sales, primarily based in Japan. Since its inception in 1968, the company has expanded its footprint globally, exporting products to around 190 countries and catering to a diverse clientele that includes public and private hospitals, universities, research institutes, and other medical facilities. With its corporate headquarters located in Kobe, Japan, Sysmex has intricately woven itself into the fabric of the global healthcare industry, providing innovative solutions in diagnostics, digital medicine, regenerative medicine, and more.

Products and Services

  • Hematology Instruments: Sysmex offers advanced instruments for white blood cell differentiation, including three-part and five-part differentiation systems, crucial for diagnosing various blood disorders.
  • Automated Urine Particle Analyzers: These sophisticated analyzers streamline the analysis of urine samples, enhancing laboratory efficiency and accuracy in diagnosing urinary tract infections and other conditions.
  • Automated Blood Coagulation Analyzers: Essential tools for assessing blood coagulation, these analyzers play a critical role in monitoring anticoagulant therapy and diagnosing coagulopathies.
  • Automated Immunochemistry Systems: Sysmex provides systems that perform assays on minute sample quantities to detect infectious diseases and tumor markers, vital for early disease detection and management.
  • Flow Cytometers: These devices are used for detailed cell analysis, crucial in the diagnosis of leukemia, lymphoma, and monitoring of HIV/AIDS.
  • Cancer Lymph Node Metastasis Testing Systems: Sysmex offers systems that help in detecting lymph node metastasis in cancer patients, providing valuable information for staging and treatment planning.
  • Lab Assay Services: Alongside manufacturing, Sysmex also provides laboratory services to analyze samples using their cutting-edge systems and reagents.
  • Diagnostic Information Systems Software: The development and sale of software solutions to integrate and manage diagnostic information, improving lab operations and patient care.
  • Regenerative Medicine Products: Researching, developing, and selling products in the burgeoning field of regenerative medicine, aiming to offer new treatments for various diseases.
  • Medical Robots and Biodevices: Sysmex is involved in marketing, developing, and servicing medical robots and biodevices that extend the automation and efficiency of healthcare delivery.
  • IT Solutions and Digital Medicine: The company is a frontrunner in digital medicine, offering IT solutions, platforms, and applications to advance medical care and research.
  • Blood DNA Testing Services: Providing DNA testing services for a variety of medical and research applications, Sysmex aids in the genetic analysis and understanding of diseases.

Contact Information

Address: 1-5-1 Wakinohama-kaigandori
Phone: 81 78 265 0500